A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a "pay-for-delay" ...

Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...

Smith ⁠Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers ...

Novo Nordisk's Victoza, a popular diabetes medication, has shown mixed results in a mid-stage trial targeting Alzheimer's disease. While the drug failed to meet its primary endpoint of improving brain ...

Danish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a ...

COPENHAGEN, April 26 (Reuters) - The world's No.1 insulin maker Novo Nordisk is expected to deliver more solid results on Tuesday with investors watching closely for comments on new blockbuster hope ...

The suit claims price-gouging by manufacturers and says the companies operated out of greed.

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

The logo of Teva Pharmaceutical Industries is displayed at the company headquarters in Tel Aviv (Reuters) -Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on ...

Novo Nordisk's Victoza, a diabetes treatment that dominates its class of drugs, was shunned by U.S. pharmacy benefits manager Express Scripts Holding Co. for at least the second year in a row, ...

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...